131 related articles for article (PubMed ID: 3084307)
61. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
Mori H; Aisaka K; Matsuoka R; Kigawa T
Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814
[TBL] [Abstract][Full Text] [Related]
62. [The response of ovarian function to HMG-HCG and bromocriptine therapies in hyperprolactinemic patients].
Matsuoka M; Imura H; Aso T; Okuda K
Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):647-58. PubMed ID: 6436078
[TBL] [Abstract][Full Text] [Related]
63. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
64. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
Soules MR; Clifton DK; Bremner WJ; Steiner RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
[TBL] [Abstract][Full Text] [Related]
65. [Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle].
Roger M; Veinante A; Soldat MC; Tardy J; Tribondeau E; Scholler R
Nouv Presse Med; 1975 Sep; 4(30):2173-8. PubMed ID: 1178478
[TBL] [Abstract][Full Text] [Related]
66. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
67. Correlation between the serum norethindrone (NET) levels attained after insertion of a silastic implant releasing norethindrone acetate and the endogenous hormones particularly progesterone.
Laumas V; Jain AK; Jha P; Rahman SA; Kumar D; Malik BK; Sarkar NN; Takkar D; Hingorani V; Laumas KR
Contraception; 1981 Feb; 23(2):211-25. PubMed ID: 6786828
[TBL] [Abstract][Full Text] [Related]
68. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women.
Jeppsson S; Rannevik G; Thorell JI; Wide L
Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431
[TBL] [Abstract][Full Text] [Related]
69. The effect of thyrotropin-releasing hormone stimulation on serum levels of gonadotropins in women during the follicular and luteal phases of the menstrual cycle.
Colon JM; Lessing JB; Yavetz C; Peyser MR; Ganguly M; Weiss G
Fertil Steril; 1988 May; 49(5):809-12. PubMed ID: 3129315
[TBL] [Abstract][Full Text] [Related]
70. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
71. Hormone changes during the menstrual cycle in abetalipoproteinemia: reduced luteal phase progesterone in a patient with homozygous hypobetalipoproteinemia.
Illingworth DR; Corbin DK; Kemp ED; Keenan EJ
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6685-9. PubMed ID: 6959145
[TBL] [Abstract][Full Text] [Related]
72. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
[TBL] [Abstract][Full Text] [Related]
73. The endocrinological profile of normal menstrual cycles in a population of Chinese women.
Xiao BL; Zhang XL; Yan WQ; Dong L; Jia MC; Lin SQ; Feng DD; Wu E
Contraception; 1985 Mar; 31(3):217-30. PubMed ID: 3922673
[TBL] [Abstract][Full Text] [Related]
74. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
Sieja K; Stanosz S
Ginekol Pol; 2002 Jul; 73(7):594-9. PubMed ID: 12375569
[TBL] [Abstract][Full Text] [Related]
75. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
76. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
Grimes EM; Thompson IE; Taymor ML
Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
[TBL] [Abstract][Full Text] [Related]
77. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase.
Sherman BM; Korenman SG
J Clin Endocrinol Metab; 1974 Jul; 39(1):145-9. PubMed ID: 4835128
[No Abstract] [Full Text] [Related]
78. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
[TBL] [Abstract][Full Text] [Related]
79. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
80. Effect of suppression of plasma prolactin on ovulation, plasma gonadotrophins and corpus luteum function in LH-RH-treated anoestrous ewes.
McNeilly AS; Land RB
J Reprod Fertil; 1979 Jul; 56(2):601-9. PubMed ID: 383978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
